Beyond Drugs: Blood-Based Therapies in Sickle Cell Disease and Beyond
At a moment when medication therapy for sickle cell disease (SCD) leaves too many behind and widespread access to curative gene therapies still lies in the distant future, automated red blood cell exchange is experiencing renewed interest. To improve patients’ lives, a broad commitment is needed to expand access to transfusion therapies. The post Beyond Drugs: Blood-Based Therapies in Sickle Cell Disease and Beyond appeared first on MedCity News.
At a moment when medication therapy for sickle cell disease (SCD) leaves too many behind and widespread access to curative gene therapies still lies in the distant future, automated red blood cell exchange is experiencing renewed interest. To improve patients’ lives, a broad commitment is needed to expand access to transfusion therapies.
The post Beyond Drugs: Blood-Based Therapies in Sickle Cell Disease and Beyond appeared first on MedCity News.
